LAVA Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $4,990 | $0 | $227 | $6,992 |
Gross Profit | 4,990 | 0 | -228 | 6,992 |
EBITDA | -1,372 | -11,073 | -9,241 | -1,808 |
EBIT | -1,152 | -11,285 | -9,469 | -1,952 |
Net Income | -3,970 | -12,296 | -8,296 | -553 |
Net Change In Cash | 4,990 | 0 | 227 | 6,992 |
Free Cash Flow | -1,405 | -8,653 | -8,384 | -1,125 |
Cash | 35,015 | 26,963 | 35,086 | 43,187 |
Basic Shares | 26,840 | 26,846 | 26,822 | 26,794 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $11,982 | $6,769 | $19,391 | $5,000 |
Gross Profit | 11,982 | 3,287 | 19,391 | 5,000 |
EBITDA | -23,502 | -40,417 | -30,877 | -43,795 |
EBIT | -23,969 | -41,695 | -31,381 | -44,353 |
Net Income | -25,114 | -41,974 | -31,907 | -45,347 |
Net Change In Cash | 11,982 | 6,769 | 19,391 | 5,000 |
Free Cash Flow | -19,567 | -39,702 | 3,456 | -33,343 |
Cash | 35,015 | 44,231 | 100,333 | 151,013 |
Basic Shares | 26,834 | 26,732 | 25,924 | 19,758 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.12 |
2024-09-30 | -$0.43 |
2024-06-30 | -$0.31 |
2024-03-31 | -$0.02 |
